Cargando…

Utilization of CRISPR-Mediated Tools for Studying Functional Genomics in Hematological Malignancies: An Overview on the Current Perspectives, Challenges, and Clinical Implications

Hematological malignancies (HM) are a group of neoplastic diseases that are usually heterogenous in nature due to the complex underlying genetic aberrations in which collaborating mutations enable cells to evade checkpoints that normally safeguard it against DNA damage and other disruptions of healt...

Descripción completa

Detalles Bibliográficos
Autores principales: Solayappan, Maheswaran, Azlan, Adam, Khor, Kang Zi, Yik, Mot Yee, Khan, Matiullah, Yusoff, Narazah Mohd, Moses, Emmanuel Jairaj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834884/
https://www.ncbi.nlm.nih.gov/pubmed/35154242
http://dx.doi.org/10.3389/fgene.2021.767298
_version_ 1784649293363150848
author Solayappan, Maheswaran
Azlan, Adam
Khor, Kang Zi
Yik, Mot Yee
Khan, Matiullah
Yusoff, Narazah Mohd
Moses, Emmanuel Jairaj
author_facet Solayappan, Maheswaran
Azlan, Adam
Khor, Kang Zi
Yik, Mot Yee
Khan, Matiullah
Yusoff, Narazah Mohd
Moses, Emmanuel Jairaj
author_sort Solayappan, Maheswaran
collection PubMed
description Hematological malignancies (HM) are a group of neoplastic diseases that are usually heterogenous in nature due to the complex underlying genetic aberrations in which collaborating mutations enable cells to evade checkpoints that normally safeguard it against DNA damage and other disruptions of healthy cell growth. Research regarding chromosomal structural rearrangements and alterations, gene mutations, and functionality are currently being carried out to understand the genomics of these abnormalities. It is also becoming more evident that cross talk between the functional changes in transcription and proteins gives the characteristics of the disease although specific mutations may induce unique phenotypes. Functional genomics is vital in this aspect as it measures the complete genetic change in cancerous cells and seeks to integrate the dynamic changes in these networks to elucidate various cancer phenotypes. The advent of CRISPR technology has indeed provided a superfluity of benefits to mankind, as this versatile technology enables DNA editing in the genome. The CRISPR-Cas9 system is a precise genome editing tool, and it has revolutionized methodologies in the field of hematology. Currently, there are various CRISPR systems that are used to perform robust site-specific gene editing to study HM. Furthermore, experimental approaches that are based on CRISPR technology have created promising tools for developing effective hematological therapeutics. Therefore, this review will focus on diverse applications of CRISPR-based gene-editing tools in HM and its potential future trajectory. Collectively, this review will demonstrate the key roles of different CRISPR systems that are being used in HM, and the literature will be a representation of a critical step toward further understanding the biology of HM and the development of potential therapeutic approaches.
format Online
Article
Text
id pubmed-8834884
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88348842022-02-12 Utilization of CRISPR-Mediated Tools for Studying Functional Genomics in Hematological Malignancies: An Overview on the Current Perspectives, Challenges, and Clinical Implications Solayappan, Maheswaran Azlan, Adam Khor, Kang Zi Yik, Mot Yee Khan, Matiullah Yusoff, Narazah Mohd Moses, Emmanuel Jairaj Front Genet Genetics Hematological malignancies (HM) are a group of neoplastic diseases that are usually heterogenous in nature due to the complex underlying genetic aberrations in which collaborating mutations enable cells to evade checkpoints that normally safeguard it against DNA damage and other disruptions of healthy cell growth. Research regarding chromosomal structural rearrangements and alterations, gene mutations, and functionality are currently being carried out to understand the genomics of these abnormalities. It is also becoming more evident that cross talk between the functional changes in transcription and proteins gives the characteristics of the disease although specific mutations may induce unique phenotypes. Functional genomics is vital in this aspect as it measures the complete genetic change in cancerous cells and seeks to integrate the dynamic changes in these networks to elucidate various cancer phenotypes. The advent of CRISPR technology has indeed provided a superfluity of benefits to mankind, as this versatile technology enables DNA editing in the genome. The CRISPR-Cas9 system is a precise genome editing tool, and it has revolutionized methodologies in the field of hematology. Currently, there are various CRISPR systems that are used to perform robust site-specific gene editing to study HM. Furthermore, experimental approaches that are based on CRISPR technology have created promising tools for developing effective hematological therapeutics. Therefore, this review will focus on diverse applications of CRISPR-based gene-editing tools in HM and its potential future trajectory. Collectively, this review will demonstrate the key roles of different CRISPR systems that are being used in HM, and the literature will be a representation of a critical step toward further understanding the biology of HM and the development of potential therapeutic approaches. Frontiers Media S.A. 2022-01-28 /pmc/articles/PMC8834884/ /pubmed/35154242 http://dx.doi.org/10.3389/fgene.2021.767298 Text en Copyright © 2022 Solayappan, Azlan, Khor, Yik, Khan, Yusoff and Moses. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Genetics
Solayappan, Maheswaran
Azlan, Adam
Khor, Kang Zi
Yik, Mot Yee
Khan, Matiullah
Yusoff, Narazah Mohd
Moses, Emmanuel Jairaj
Utilization of CRISPR-Mediated Tools for Studying Functional Genomics in Hematological Malignancies: An Overview on the Current Perspectives, Challenges, and Clinical Implications
title Utilization of CRISPR-Mediated Tools for Studying Functional Genomics in Hematological Malignancies: An Overview on the Current Perspectives, Challenges, and Clinical Implications
title_full Utilization of CRISPR-Mediated Tools for Studying Functional Genomics in Hematological Malignancies: An Overview on the Current Perspectives, Challenges, and Clinical Implications
title_fullStr Utilization of CRISPR-Mediated Tools for Studying Functional Genomics in Hematological Malignancies: An Overview on the Current Perspectives, Challenges, and Clinical Implications
title_full_unstemmed Utilization of CRISPR-Mediated Tools for Studying Functional Genomics in Hematological Malignancies: An Overview on the Current Perspectives, Challenges, and Clinical Implications
title_short Utilization of CRISPR-Mediated Tools for Studying Functional Genomics in Hematological Malignancies: An Overview on the Current Perspectives, Challenges, and Clinical Implications
title_sort utilization of crispr-mediated tools for studying functional genomics in hematological malignancies: an overview on the current perspectives, challenges, and clinical implications
topic Genetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834884/
https://www.ncbi.nlm.nih.gov/pubmed/35154242
http://dx.doi.org/10.3389/fgene.2021.767298
work_keys_str_mv AT solayappanmaheswaran utilizationofcrisprmediatedtoolsforstudyingfunctionalgenomicsinhematologicalmalignanciesanoverviewonthecurrentperspectiveschallengesandclinicalimplications
AT azlanadam utilizationofcrisprmediatedtoolsforstudyingfunctionalgenomicsinhematologicalmalignanciesanoverviewonthecurrentperspectiveschallengesandclinicalimplications
AT khorkangzi utilizationofcrisprmediatedtoolsforstudyingfunctionalgenomicsinhematologicalmalignanciesanoverviewonthecurrentperspectiveschallengesandclinicalimplications
AT yikmotyee utilizationofcrisprmediatedtoolsforstudyingfunctionalgenomicsinhematologicalmalignanciesanoverviewonthecurrentperspectiveschallengesandclinicalimplications
AT khanmatiullah utilizationofcrisprmediatedtoolsforstudyingfunctionalgenomicsinhematologicalmalignanciesanoverviewonthecurrentperspectiveschallengesandclinicalimplications
AT yusoffnarazahmohd utilizationofcrisprmediatedtoolsforstudyingfunctionalgenomicsinhematologicalmalignanciesanoverviewonthecurrentperspectiveschallengesandclinicalimplications
AT mosesemmanueljairaj utilizationofcrisprmediatedtoolsforstudyingfunctionalgenomicsinhematologicalmalignanciesanoverviewonthecurrentperspectiveschallengesandclinicalimplications